Cargando…
Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease
Autor principal: | Kelly, Clive |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612840/ https://www.ncbi.nlm.nih.gov/pubmed/36320826 http://dx.doi.org/10.1016/S2665-9913(22)00256-9 |
Ejemplares similares
-
Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis
por: Koduri, Gouri Mani, et al.
Publicado: (2023) -
Flare of rheumatoid arthritis after COVID-19 vaccination
por: Terracina, Katherine A, et al.
Publicado: (2021) -
Are women with asthma at increased risk for severe COVID-19?
por: Fernando, Mario, et al.
Publicado: (2021) -
Predicting outcomes in rheumatoid arthritis related interstitial lung disease
por: Jacob, Joseph, et al.
Publicado: (2019) -
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis
por: Vacchi, Caterina, et al.
Publicado: (2021)